Although it has previously been demonstrated that combining SOFA score with some biomarkers such as calprotectin and cystatin C could also improve the prediction of AKI, these biochemical indices are not routinely tested in most patients, making it easy to miss high-risk patients (42). This evidence concerns the gene CST3 and acute kidney injury.